Arachidonic Acid Market in North America 2024-2028

Description

List of Tables

The arachidonic acid market in North America is forecasted to grow by USD 37.41 mn during 2023-2028, accelerating at a CAGR of 8.15% during the forecast period. The report on the arachidonic acid market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for sports supplements, rising awareness about preventative healthcare, and the increasing number of working mothers.

Technavio's arachidonic acid market in North America is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	7.72%
CAGR	8.15%
Incremental Value	$37.41mn

By Application

Infant formula
Others

By Source

Plant source
Animal source

This study identifies the e-commerce channels gaining popularity as one of the prime reasons driving the arachidonic acid market in North America growth during the next few years. Also, increasing demand for baby food products and proliferating demand for personalized supplement solutions will lead to sizable demand in the market.

The report on the arachidonic acid market in North America covers the following areas:

Arachidonic acid market in North America sizing
Arachidonic acid market in North America forecast
Arachidonic acid market in North America industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading arachidonic acid market in North America vendors that include Avantor Inc., BASF SE, Bio Techne Corp., Biosynth Ltd., Cargill Inc., Cayman Chemical, Croda International Plc, Koninklijke DSM NV, LGC Science Group Holdings Ltd., Merck KGaA, Parchem Fine and Specialty Chemicals Inc., PerkinElmer Inc., Selleck Chemicals LLC, Sisco Research Laboratories Pvt. Ltd., Spectrum Laboratory Products Inc., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co. Ltd., Wanrun Co. Ltd., Xiamen Jindawei Group Co. Ltd., and Zhejiang Tianhecheng Bio technology Shares Co. Ltd.. Also, the arachidonic acid market in North America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72655

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Source
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on North America: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)

4 Historic Market Size

4.1 Arachidonic acid market in North America 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on arachidonic acid market in north America 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Source Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Source Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 22: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 25: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 26: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 27: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 29: Chart on Application - Market share 2023-2028 (%)
Exhibit 30: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 31: Chart on Comparison by Application
Exhibit 32: Data Table on Comparison by Application
6.3 Infant formula - Market size and forecast 2023-2028
Exhibit 33: Chart on Infant formula - Market size and forecast 2023-2028 ($ million)
Exhibit 34: Data Table on Infant formula - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Chart on Infant formula - Year-over-year growth 2023-2028 (%)
Exhibit 36: Data Table on Infant formula - Year-over-year growth 2023-2028 (%)
6.4 Others - Market size and forecast 2023-2028
Exhibit 37: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 38: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 40: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 41: Market opportunity by Application ($ million)
Exhibit 42: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Source

7.1 Market segments
Exhibit 43: Chart on Source - Market share 2023-2028 (%)
Exhibit 44: Data Table on Source - Market share 2023-2028 (%)
7.2 Comparison by Source
Exhibit 45: Chart on Comparison by Source
Exhibit 46: Data Table on Comparison by Source
7.3 Plant source - Market size and forecast 2023-2028
Exhibit 47: Chart on Plant source - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Data Table on Plant source - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Chart on Plant source - Year-over-year growth 2023-2028 (%)
Exhibit 50: Data Table on Plant source - Year-over-year growth 2023-2028 (%)
7.4 Animal source - Market size and forecast 2023-2028
Exhibit 51: Chart on Animal source - Market size and forecast 2023-2028 ($ million)
Exhibit 52: Data Table on Animal source - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Chart on Animal source - Year-over-year growth 2023-2028 (%)
Exhibit 54: Data Table on Animal source - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Source
Exhibit 55: Market opportunity by Source ($ million)
Exhibit 56: Data Table on Market opportunity by Source ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 58: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibit 59: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
9.2 Geographic comparison
Exhibit 60: Chart on Geographic comparison
Exhibit 61: Data Table on Geographic comparison
9.3 US - Market size and forecast 2023-2028
Exhibit 62: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2023-2028 (%)
9.4 Canada - Market size and forecast 2023-2028
Exhibit 66: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.5 Mexico - Market size and forecast 2023-2028
Exhibit 70: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibit 71: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibit 73: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity By Geographical Landscape
Exhibit 74: Market opportunity By Geographical Landscape ($ million)
Exhibit 75: Data Table on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 76: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 78: Overview on factors of disruption
11.4 Industry risks
Exhibit 79: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 80: Vendors covered
12.2 Market positioning of vendors
Exhibit 81: Matrix on vendor position and classification
12.3 Avantor Inc.
Exhibit 82: Avantor Inc. - Overview
Exhibit 83: Avantor Inc. - Business segments
Exhibit 84: Avantor Inc. - Key offerings
Exhibit 85: Avantor Inc. - Segment focus
12.4 BASF SE
Exhibit 86: BASF SE - Overview
Exhibit 87: BASF SE - Business segments
Exhibit 88: BASF SE - Key news
Exhibit 89: BASF SE - Key offerings
Exhibit 90: BASF SE - Segment focus
12.5 Biosynth Ltd.
Exhibit 91: Biosynth Ltd. - Overview
Exhibit 92: Biosynth Ltd. - Product / Service
Exhibit 93: Biosynth Ltd. - Key offerings
12.6 Cargill Inc.
Exhibit 94: Cargill Inc. - Overview
Exhibit 95: Cargill Inc. - Product / Service
Exhibit 96: Cargill Inc. - Key news
Exhibit 97: Cargill Inc. - Key offerings
12.7 Cayman Chemical
Exhibit 98: Cayman Chemical - Overview
Exhibit 99: Cayman Chemical - Product / Service
Exhibit 100: Cayman Chemical - Key offerings
12.8 Croda International Plc
Exhibit 101: Croda International Plc - Overview
Exhibit 102: Croda International Plc - Business segments
Exhibit 103: Croda International Plc - Key news
Exhibit 104: Croda International Plc - Key offerings
Exhibit 105: Croda International Plc - Segment focus
12.9 Koninklijke DSM NV
Exhibit 106: Koninklijke DSM NV - Overview
Exhibit 107: Koninklijke DSM NV - Business segments
Exhibit 108: Koninklijke DSM NV - Key news
Exhibit 109: Koninklijke DSM NV - Key offerings
Exhibit 110: Koninklijke DSM NV - Segment focus
12.10 Merck KGaA
Exhibit 111: Merck KGaA - Overview
Exhibit 112: Merck KGaA - Business segments
Exhibit 113: Merck KGaA - Key news
Exhibit 114: Merck KGaA - Key offerings
Exhibit 115: Merck KGaA - Segment focus
12.11 Parchem Fine and Specialty Chemicals Inc.
Exhibit 116: Parchem Fine and Specialty Chemicals Inc. - Overview
Exhibit 117: Parchem Fine and Specialty Chemicals Inc. - Product / Service
Exhibit 118: Parchem Fine and Specialty Chemicals Inc. - Key offerings
12.12 PerkinElmer Inc.
Exhibit 119: PerkinElmer Inc. - Overview
Exhibit 120: PerkinElmer Inc. - Business segments
Exhibit 121: PerkinElmer Inc. - Key news
Exhibit 122: PerkinElmer Inc. - Key offerings
Exhibit 123: PerkinElmer Inc. - Segment focus
12.13 Selleck Chemicals LLC
Exhibit 124: Selleck Chemicals LLC - Overview
Exhibit 125: Selleck Chemicals LLC - Product / Service
Exhibit 126: Selleck Chemicals LLC - Key offerings
12.14 Spectrum Laboratory Products Inc.
Exhibit 127: Spectrum Laboratory Products Inc. - Overview
Exhibit 128: Spectrum Laboratory Products Inc. - Product / Service
Exhibit 129: Spectrum Laboratory Products Inc. - Key offerings
12.15 Thermo Fisher Scientific Inc.
Exhibit 130: Thermo Fisher Scientific Inc. - Overview
Exhibit 131: Thermo Fisher Scientific Inc. - Business segments
Exhibit 132: Thermo Fisher Scientific Inc. - Key news
Exhibit 133: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 134: Thermo Fisher Scientific Inc. - Segment focus
12.16 Wanrun Co. Ltd.
Exhibit 135: Wanrun Co. Ltd. - Overview
Exhibit 136: Wanrun Co. Ltd. - Product / Service
Exhibit 137: Wanrun Co. Ltd. - Key offerings
12.17 Xiamen Jindawei Group Co. Ltd.
Exhibit 138: Xiamen Jindawei Group Co. Ltd. - Overview
Exhibit 139: Xiamen Jindawei Group Co. Ltd. - Product / Service
Exhibit 140: Xiamen Jindawei Group Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 141: Inclusions checklist
Exhibit 142: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 143: Currency conversion rates for US$
13.4 Research methodology
Exhibit 144: Research methodology
Exhibit 145: Validation techniques employed for market sizing
Exhibit 146: Information sources
13.5 List of abbreviations
Exhibit 147: List of abbreviations